We reported earlier that in cell extracts that were prepared from interferontreated Ehrlich ascites tumor cells and preincubated and passed through Sephadex G-25 (S3OINT), the translation of exogenous mRNA (viral and host) was impaired and the impairment could be overcome to a large extent by adding a crude tRNA preparation from Ehrlich ascites tumor cells but not from Escherichia coli. We find now that the rate of inactivation of some tRNA's (especially those specific for leucine, lysine, and serine) but not those of many others is faster in S30INT than in corresponding extracts from control cells. This increased rate of tRNA inactivation may perhaps account for the need for added RNA to overcome at least partially the impairment of translation in S301NT. The relationship of the increased rate of tRNA inactivation to the antiviral effect of interferon is unclear. So far no significant difference has been detected in the amount of tRNA needed to overcome the impairment of encephalomyocarditis virus RNA translation in S301mr between tRNA from interferon-treated cells and tRNA from control cells. Furthermore, no difference was found in the rate of inactivation in S30INT between leucine-specific tRNA's from interferontreated and from control cells. tRNA's specific for leucine and lysine were not inactivated (unless very slowly) during incubation under our conditions in an extract from interferon-treated (or from control) cells unless the extract had been passed through Sephadex G-25 or dialyzed. The translation of exogenous mRNA was, however, impaired in an extract from interferon-treated cells that had not been passed through Sephadex G-25. overcome by added tRNA.
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This impairment was apparently not
Interferons are macromolecules (presumably glycoproteins) that are formed in various animal cells upon viral infection or some other stimuli. They are released from the producing cells, interact with other cells, and make these inefficient in supporting the multiplication of a large variety of animal viruses. The nature of the block in virus replication in interferontreated cells is under investigation (9) . In the case of reovirus, the adsorption and penetration into the cell and the uncoating of the virus are apparently not inhibited in interferon-treated cells, whereas the accumulation of virus-specific proteins and RNA is (14, 17, 43; M. E. Wiebe and W. K. Joklik, Abstr. Am. Soc. Microbiol. 1973, V97, p. 210; R. Galster et al., manuscript in preparation). We do not know whether the block in viral protein accumulation is a consequence of an impairment of viral RNA metabolism (e.g., of transcription, processing, or turnover) or of the translation of viral mRNA or both.
We have been studying the effect of treating cells (L-929 mouse fibroblasts and Ehrlich ascites tumor [EAT] cells) with a partially purified mouse interferon preparation on the capacity of their extracts to translate exogenous and endogous mRNA's (17, 18) . The extracts from interferon-treated and control cells were usually "preincubated" and filtered through Sephadex G-25 (S30,NT and S30C) to decrease protein synthesis resulting from the translation of endogenous mRNA. Under our conditions the translation of viral and cellular mRNA's was less in S30,, than in S30C. In S30c the translation of encephalomyocarditis (EMC) virus RNA proceeded at a linear rate for over 90 min, whereas in S30INT the translation proceeded usually at a somewhat lower rate than in S30c for about 30 min and then ceased. The impairment of translation in S301NT was apparently due to the action of one (or more) inhibitor loosely bound to the ribosomes (18) . Some time ago it was established that the translation of exogenous mRNA in S30, NT (which ceased after about 30 min of incubation) could be restored by the addition of crude tRNA (7, 19 7 .5], 800 mM KCl, 40 mM magnesium acetate, 60 mM 2-mercaptoethanol, and 10 mM dithiothreitol) and centrifuged at 20,000 x g for 20 min. The supernatant fraction was diluted with an equal volume of water and put on a DEAE-cellulose column. (This column had been equilibrated earlier with buffer A [10 mM Tris-chloride, pH 7.5, 1 mM magnesium acetate, and 10 mM 2-mercaptoethanol].) Thereafter the column was first washed with buffer A and then (to elute proteins) with the same buffer containing 0.25 M KCl. The protein-rich fractions were pooled, and the proteins precipitating between 40 and 70% (wt/vol) ammonium sulfate saturation were dissolved in a minimal volume of buffer A. The solution was passed through a column of Sephadex G-25 to remove residual ammonium sulfate. The excluded fraction (containing the aminoacyl-tRNA synthetase) was stored in 50% glycerol at -25 C.
Rabbit reticulocyte ribosomal wash fluid. Rabbit reticulocyte ribosomal wash fluid, serving as a source for initiation factors for globin mRNA translation, was prepared according to Shafritz and Anderson (38) .
Antisera. An antiserum against EMC virion proteins was prepared by injecting EMC virion proteins into rabbits, following the procedure of Graziadei et al. (16) RESULTS Competition between mouse globin mRNA and mengovirus RNA for translation in cellfree systems from interferon-treated and control cells. In the past we tested the effect of interferon treatment on the translation of a single type of exogenous mRNA at a time (17, 18) . In vivo, however, many types of mRNA's are translated at the same time. To get closer to the in vivo situation, we proceeded to examine the influence of the addition of various amounts of mengovirus RNA on the translation of mouse globin mRNA (see also 22; M. B. Mathews and A. Korner, Biochem J. 109:23P-24P; J. LucasLenard, personal communication). The extracts of interferon-treated and control cells used in these studies had been preincubated and Sephadex treated and were not supplemented with exogenous tRNA. For determining the amount of each of the two sets of proteins (i.e., mengovirus proteins and globins) synthesized in our extracts, we performed immunoprecipitation with an antiserum against EMC virion proteins (which cross-reacted with mengovirus proteins) and with an anitserum against mouse globins.
The translation of globin mRNA was inhibited by mengovirus RNA in both S30c and S30INT (Fig. 1) (ii) When both mRNA's were present in the same reaction mixture, the translation of globin mRNA was much more depressed than that of mengovirus RNA in both S30c and S30INT (cf. line 5 with 9 and line 7 with 11). Thus under these conditions mengovirus RNA is a more efficient competitor for translation than globin mRNA (see also Reference 22 .) The amount of cold acidinsoluble product (consisting of aminoacyltRNA and perhaps some of its cleavage products, i.e., aminoacyl-oligonucleotides) was determined in aliquots taken at the times indicated in the figure. It can be seen that the time course of the aminoacylation was most strongly affected by interferon treatment in the cases of leucine, lysine, and serine-specific tRNA's. In S30INT the charging with these three amino acids was less and the amount of aminoacyltRNA decreased much faster than in the corresponding S30c. There was a less pronounced effect of interferon treatment in the cases of isoleucine-, phenylalanine-, and tyrosinespecific tRNA's. As far as the charging of all other amino acids is concerned, the effect of interferon treatment was not obvious. (This was the case although the amount of some of these, apparently unaffected, aminoacyl-tRNA's [e.g., glutamyl-tRNA] was decreasing fast in both S30c and S30INT during incubation.)
Most of the further studies on the effect of interferon treatment on the time course of tRNA charging were restricted to the case of leucine. The curves in Fig. 3A reveal that the agent(s) responsible for the fact that the amount of leucyl-tRNA decreased faster in S30INT than in S30c was dominant. They clearly indicate also that the amount of leucyl-tRNA decreased even in S30c, only more slowly than in S301NT. Moreover, the curves reveal that aminoacyl-tRNA synthetase addition did not restore the charging of tRNA with leucine in a reaction mixture in which the amount of leucyltRNA had decreased during earlier incubation.
When, however, tRNA (instead of aminoacyltRNA synthetase) was added to the reaction mixtures, this became acylated with leucine rapidly both in the case of S30c and S30INT (Fig.   3B ). These results indicate that the decrease in leucyl-tRNA in S301NT and in S30c was due to the inactivation of leucine-specific tRNA and not of leucyl-tRNA synthetase.
It was conceivable that the fact that less leucine could be charged to tRNA in S30INT than in S30C even initially could have been caused by the faster inactivation of leucinespecific tRNA in S30INT than in S30c during the initial charging. The results in Table 2 show J. VIROL. that this was indeed the case. For this experiment tRNA was isolated from extracts that had not been preincubated but were passed through Sephadex at 4 C. The data reveal that in these extracts the leucine acceptance and valine acceptance were not much affected by interferon treatment. Other aliquots from the same not preincubated but Sephadex-treated S30c and S30INT were incubated at 37 C for 60 min and tRNA was isolated from both. The amino acid acceptance of these two tRNA preparations (lines 3 and 4) was very different: (i) leucine acceptance decreased upon incubation by 49% in S30C and by much more, 96%, in S30INT; and (ii) there was much less difference in the decrease in valine acceptance upon incubation between S30C and S30INT (33% in S30c and 52% in S30INT). Also, valine acceptance decreased much less during incubation in S30INT than leucine acceptance.
Attempts to relate the increased rate of tRNA inactivation in Sephadex-treated S30INT to the antiviral effects of interferon. Finding that tRNA preparations isolated from Sephadex-treated but not incubated extracts from interferon-treated and control cells had similar (if not identical) capacities for accepting leucine prompted us to compare the leucine acceptance of tRNA preparations isolated directly from interferon-treated and control cells. The data in Table 2 reveal that these were the same, within the limits of the accuracy of the assay. Moreover we found no significant difference in leucine acceptance between tRNA preparations isolated from EMC virus-infected cells and tRNA preparations isolated from interferon-treated and EMC virus-infected cells. The same was found to be the case of valine acceptance. These results indicate that the increased rate of tRNA inactivation caused by the treatment of cells with interferon is only manifested in Sephadex-treated and incubated cell extracts.
We also tested whether the RNA species that can restore EMC RNA translation in S30INT (which had ceased after a 30-min incubation) were present in smaller amounts in interferontreated cells than in control cells. A comparison of the activity of tRNA preparations isolated from interferon-treated and from control cells in boosting the translation of EMC RNA in S30INT revealed no such difference (Fig. 4) ; each of the two tRNA preparations increased the translation over fivefold, and the saturating concentrations of the two were indistinguishable. However, tRNA isolated from S30INT that had been Sephadex-treated and incubated for 30 RNA in S30INT than tRNA isolated from S30INT that had been Sephadex treated but not incubated (data not shown). These results are consistent with the possibility that incubation of Sephadex-treated S30I NTresults in the inactivation of RNA species involved in translation.
Inactivation of leucine-specific tRNA is very slow during incubation of not Sephadextreated extracts from interferon-treated or control cells. During our studies on leucinespecific tRNA inactivation in cell extracts, we compared the time course of leucine charging to tRNA in Sephadex-treated and not Sephadextreated extracts from interferon-treated and control cells (Fig. 5) . The tests were run at two concentrations of S30. As shown already in Fig. the inactivation of leucine-specific tRNA in S30INT is slowed down. The agents whose addition to a Sephadex-treated S301NT had such an effect included calcium ions, sodium ions, spermine, spermidine, and ATP; S-adenosylmethionine and S-adenosylhomocysteine had no such effect (G. E. Brown et al., unpublished data).
Translation of exogenous mRNA is impaired even in not Sephadex-treated extracts from interferon-treated cells. This impairment is apparently not overcome by added tRNA. The finding that in not preincubated and not Sephadex-treated extracts from interferon-treated cells tRNA's are quite stable prompted us to test whether translation of exogenous mRNA was inhibited in these conditions. Since in such extracts much endogenous protein synthesis was going on, we had to assay for exogenous mRNA-promoted protein synthesis by immunoprecipitation of the products. The curves in Fig. 6 reveal that EMC RNA was less efficiently translated in such a not preincubated, not Sephadex-treated extract from interferon-treated cells than in a corresponding extract of cells not treated with interferon (see also reference 11). The difference in the rate of translation between the two extracts was manifested from the beginning of the incubation. The curves in Fig. 6A indicate that the impairment of EMC RNA translation in the same S30INT could also be noted by precipitation of the products of the translation by the nonspecific precipitant hot trichloroacetic acid. The addition of tRNA did not seem to overcome the impairment of EMC RNA translation in this S30INT which had not been preincubated and treated with Sephadex (Table 3) . DISCUSSION tRNA inactivation in an extract from interferon-treated cells that was passed through Sephadex G-25. The data presented reveal that the endogenous amino acid acceptance of some tRNA species decreased faster in S30INT that was passed through a Sephadex G-25 column than in identically treated S30c. This difference in the rate of decrease of endogenous amino acid acceptance between S30INT and S30c was the most pronounced in the cases of leucine, lysine, and serine and less pronounced in the cases of isoleucine, phenylalanine, and tyrosine. No significant difference was detected under our assay conditions in the cases of the other amino acids. In the case of leucine acceptance (the only case examined in detail), the decrease was not due to an impairment of leucyl-tRNA synthetase but to an inactivation of tRNA. Since the acceptance decreased greatly, several (if not all) of the leucine isoacceptors must have been affected. The factor(s) responsible for the faster inactivation in S30INT was dominant.
The products of the inactivation have not yet been identified. tRNA that had been extracted from an incubated, Sephadex-treated S30,T could be charged with less leucine than tRNA extracted from a fresh S3WINT. It is also conceivable that tRNA inactivation may be induced in interferon-treated, virusinfected cells only later in infection when actual cell death is beginning. If this were the case, the tRNA effect would not be the basis for the selectivity of interferon action. However, according to Content et al. (7), the restoration of globin mRNA translation in S30INT requires a RNA species different from that needed for the restoration of mengovirus RNA translation. Thus, according to these data, the tRNA effect might, at least in principle, account for the selectivity of interferon action. It should be emphasized that the RNA species restoring translation have not been identified; though their size is identical to those of tRNA's, it still remains to be established that they are tRNA species (7) .
Some selectivity in the impairment of translation between different mRNA's was revealed in our experiments on the competition for translation between mouse globin mRNA and mengovirus RNA in S30c and in S30ONT that had been passed through a Sephadex G-25 column and were not supplemented with exogenous tRNA. The translation of mengovirus RNA in S301NT was more impaired in all cases (percentage of inhibition 80, 86, 88, and 95, average value 87.25) than that of mouse globin mRNA (percentage of inhibition 25, 44, 48, and 60, average value 44.25). The physiological relevance of the apparent selectivity in these conditions remains to be established.
Impairment of the translation of exogenous mRNA in an extract from interferon-treated cells that was not treated with Sephadex. We were prompted to test the effect of interferon treatment on the translation of exogenous mRNA in cell extracts that had not been treated with Sephadex by finding that in such extracts the tRNA's specific for leucine and lysine were quite stable. The results of the tests indicate that EMC RNA translation was impaired in such an extract of interferon-treated cells and that the impairment could not be overcome by the addition of tRNA. The mechanism of the inhibition of translation in these extracts is under investigation. Preliminary results seem to indicate that the inhibition may be due to one or more dominant inhibitors. It should be noted that not preincubated and not Sephadex-treated extracts from interferontreated L cells were tested earlier by Friedman et al. (11) for their capacity to translate EMC RNA. These authors described a small (about 10%) inhibition of translation in such extracts from cells that had been treated with 5 U of interferon per ml. (They reported, however, finding a much more extensive inhibition of translation in such extracts from cells that had been treated with interferon and were subsequently infected with vaccinia virus.)
Problems of elucidating the mechanisms of the antiviral actions of interferons. The understanding of the molecular basis of the (possibly more than one) way in which the replication of different viruses is blocked in various types of interferon-treated cells will have to be based on compatible results from experiments with intact cells and their extracts.
Results of experiments with intact cells reveal the selective nature of interferon action. Thus, uninfected cells can be grown for many generations (30, 32) in the presence of interferon at a concentration that blocks the replication of various viruses, and some enzymes and other proteins can be induced in them (24, 44) .
Most of the studies with intact cells point to one of two processes as the primary targets of interferon action: (i) the transcription of early viral mRNA (2, 3, 14, 15, 25, 26, 33; M. N. Oxman, personal communication); and (ii) the translation of early viral mRNA (4, 10, 20, 23, 28, 29, 34, 40) . The inhibition of viral RNA synthesis in vitro has not yet been reported, only an accelerated degradation (27) . There are several reports on the inhibition of viral mRNA translation in vitro (8, 11, 36) , some of which have been cited here.
Many eukaryotic cellular and viral mRNA's (including reovirus mRNA) carry a methyl group attached to their 5' terminal guanylate resicdde (12, 13, 25, 45) . This methyl group is apparently required for translation (6) . We found recently that the conversion of unmethyylated reovirus mRNA into the methylated form is impaired in extracts of interferontreated cells (37) .
